51 citations
,
January 2024 in “Nanoscale” Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.
66 citations
,
January 2008 in “Pharmacology Biochemistry and Behavior” AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.
23 citations
,
October 2008 in “Journal of medicinal chemistry” PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.
6 citations
,
March 2023 in “Materials” The GNP crosslinked scaffold with antibacterial coating is effective for rapid wound healing and infection prevention.
January 2025 in “Journal of Crohn s and Colitis” Tofacitinib is effective and safe for elderly patients with ulcerative colitis.
9 citations
,
January 2014 in “Molecular Genetics and Metabolism Reports” The rhg mutation in mice affects the Oat gene, causing hair growth issues and other symptoms.
October 2025 in “Journal of Cosmetic Dermatology” AOPT-MTL effectively and safely treats nasal blackheads in Asians.
Suppressing ODC activity reduces tumor growth in hair follicles.
24 citations
,
December 2020 in “Kardiologiia” Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.
20 citations
,
July 2000 in “PubMed” The document outlines a method for diagnosing hair loss and suggests specific treatments based on the diagnosis.
14 citations
,
November 2023 in “Mycoses” Kerion Celsi in children is treated with antifungals, not surgery, to prevent scarring.
6 citations
,
January 2019 in “Journal of lasers in medical sciences” Using a fractional CO2 laser helps Minoxidil work better for hair regrowth.
4 citations
,
July 2018 in “International Journal of Research in Dermatology” Topical finasteride with minoxidil is effective for treating hair loss and may reduce the need for oral finasteride.
2 citations
,
March 2023 in “Aesthetic Plastic Surgery” The new hair transplant method reduces scarring and wastage by combining two techniques.
2 citations
,
November 2017 in “International Journal of Research in Dermatology” Premature hair loss doesn't increase the risk of metabolic syndrome.
2 citations
,
June 2016 in “European Journal of Plastic Surgery” Dermal filler injections can cause complications like swelling and infections, often appearing years later.
1 citations
,
May 2022 in “Reproductive Endocrinology” Conditioned media from glial cell cultures improved uterine contractions in older rats.
1 citations
,
January 2022 in “Springer eBooks”
1 citations
,
January 2010 Asian women experiencing hair loss often feel embarrassed and unhappy, but hair transplantation can offer natural-looking results and improve their self-confidence.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments mainly slowing it down.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments to slow it but no cure.
December 2025 in “Çukurova medical journal (Online)/Çukurova medical journal” Certain genetic markers and low vitamin D3 levels are linked to male pattern baldness.
August 2025 in “Archives of Dermatological Research” Oral minoxidil is more effective than topical minoxidil for hair growth in men.
July 2025 in “Pakistan Journal of Medicine and Dentistry” Smoking increases the risk and severity of male pattern baldness.
May 2025 in “Anadolu Kliniği Tıp Bilimleri Dergisi” Gene variations may increase oxidative stress in male pattern baldness.
May 2025 in “International Journal of Applied Pharmaceutics” Nanocarriers could improve hair loss treatments by delivering drugs directly to hair follicles.
April 2025 in “International Journal of Research in Dermatology” Combining Ayurvedic therapies with minoxidil is more effective for hair growth in men than using minoxidil alone.
October 2024 in “Archives of Dermatological Research” Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.